Related Experiment Video
Updated: Jan 11, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Regulation of cellular states via targeted phosphorylation of p53 using a nanobody-coupled kinase system
Hoe Eun Lim1, Hae Yong Yoo2,3
1Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Abstract:
Phosphorylation participates in numerous signal transduction processes, including proliferation, differentiation, apoptosis, and cellular response to stimuli. Understanding its regulatory mechanisms is essential for advancing therapeutic interventions. In this study, we developed a target protein phosphorylation (TPP) system, consisting of a nanobody fused to a kinase domain, to investigate its ability to phosphorylate target proteins and regulate their cellular characteristics. We first verified that the nanobody-coupled kinase effectively phosphorylates GFP. Subsequently, we focused on p53 phosphorylation, identifying specific phosphorylation sites targeted by the system. This phosphorylation resulted in stabilization of p53 protein levels, inducing p21 expression, delaying cell cycle progression and suppressing cell growth. Furthermore, combining the TPP system with chemotherapeutic drugs (5-Fluorouracil and Oxaliplatin) enhanced cytotoxicity in colorectal cancer cells. The TPP system achieved p53 phosphorylation without external stimuli, inducing a DNA-damaged state in cells. In vivo, doxycycline-induced expression of the TPP system in a xenograft mouse model significantly inhibited tumor growth. This work demonstrates the ability to phosphorylate key regulatory proteins and alter cellular states, suggesting applications in studying phosphorylation-related pathways and developing therapies for diseases associated with dysregulated phosphorylation.
Insights
Researchers developed a target protein phosphorylation (TPP) system to control cell behavior by phosphorylating key proteins like p53. This system shows promise for cancer therapy by inhibiting tumor growth and enhancing drug efficacy.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Phosphorylation is crucial for cell signaling, affecting processes like proliferation, differentiation, and apoptosis.
- Understanding phosphorylation's regulatory mechanisms is key for developing new therapeutic strategies.
- Dysregulated phosphorylation is implicated in various diseases, highlighting the need for precise control mechanisms.
Purpose of the Study:
- To develop and validate a novel target protein phosphorylation (TPP) system for precise control of protein phosphorylation.
- To investigate the TPP system's ability to phosphorylate target proteins and modulate cellular characteristics.
- To explore the therapeutic potential of the TPP system in cancer models.
Main Methods:
- Development of a TPP system comprising a nanobody fused to a kinase domain.
- Verification of the system's phosphorylation activity using GFP as a model substrate.
- Analysis of p53 phosphorylation sites and downstream effects on cell cycle and growth.
- In vitro combination studies with chemotherapeutic drugs (5-Fluorouracil, Oxaliplatin).
- In vivo evaluation using a doxycycline-inducible TPP system in a colorectal cancer xenograft mouse model.
Main Results:
- The TPP system successfully phosphorylated GFP and specifically targeted p53 at identified sites.
- p53 phosphorylation led to protein stabilization, increased p21 expression, cell cycle delay, and suppressed cell growth.
- Combined TPP system and chemotherapy significantly enhanced cytotoxicity in colorectal cancer cells.
- The TPP system induced a DNA-damaged cellular state without external stimuli.
- In vivo, doxycycline-induced TPP expression markedly inhibited tumor growth in a xenograft model.
Conclusions:
- The TPP system provides a novel method for targeted protein phosphorylation and cellular state modulation.
- This technology offers potential applications in studying phosphorylation-dependent pathways and developing therapies for phosphorylation-related diseases.
- The TPP system demonstrates significant potential for cancer treatment, both as a standalone therapy and in combination with existing chemotherapeutics.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

